Phase 3 Children’s and Teen Migraine Research Study
● Now Enrolling
Meridian is conducting a research study for an investigational migraine medication for children and teens. The medication being studied is currently approved for use by people aged 18 and older in the U.S. to help prevent migraines.
Eligible participants…
- Must be ages 6 to 17
- Must have experienced migraines for at least one year
- Must have experienced 14 or less headache days, of which 4 or less were migraines, per month in each of the past 3 months
- Will receive compensation for participation in the study
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for your child.
You can talk to a Meridian enrollment specialist about this study by calling (712) 639-6200.
Submit your information
Study Location
Meridian Clinical Research
2115 N. Kansas Ave., Suite 104
Hastings, NE 68901
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.
© 2022 MERIDIAN CLINICAL RESEARCH, LLC | Privacy Policy